Stockreport

Cassava settles SEC charges related to Alzheimer's candidate for $40M [Seeking Alpha]

Cassava Sciences, Inc.  (SAVA) 
Last cassava sciences, inc. earnings: 8/12 08:30 am Check Earnings Report
PDF Securities and Exchange Commission (SEC) that the drug developer made misleading claims about the 2020 trial results of its Alzheimer's drug candidate, simufilam. The [Read more]